Effect of Omidenepag Eye Drop on Optic Nerve Head Microcirculation, Shape of Optic Disc and Visual Field.

Not Applicable

Recruiting

• Conditions: Primary Open Angle Glaucoma

• Registration Number: JPRN-UMIN000040222
• Lead Sponsor: Osaka Medical and Pharmaceutical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-23
• Study Completion: 2022-12-04
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Patient with Ocular Eye Disease Except for Glaucoma, High Myopia ( more than 6D ), Systemic Diseases which Treatment influences Ocular Blood Flow, Ocular Opacity witch interrupt Ocular Funds Observation, Allergy to Omidenepag

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Optic Nerve Head Microcirculation (Before and 3, 6, 12 Month after administration )

Secondary Outcome Measures

Name	Time	Method
Intraocular Pressure, Blood Pressure, Pulse Rate, Shape of Optic, Disc, Humphrey Visual Field (Before and 3, 6, 12 Month after administration )